BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 22562252)

  • 1. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
    Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
    Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine Met signaling triggers epithelial-mesenchymal transition in mammary luminal progenitors, affecting their fate.
    Di-Cicco A; Petit V; Chiche A; Bresson L; Romagnoli M; Orian-Rousseau V; Vivanco Md; Medina D; Faraldo MM; Glukhova MA; Deugnier MA
    Elife; 2015 Jul; 4():. PubMed ID: 26165517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.
    Tornillo G; Elia AR; Castellano I; Spadaro M; Bernabei P; Bisaro B; Camacho-Leal Mdel P; Pincini A; Provero P; Sapino A; Turco E; Defilippi P; Cabodi S
    Stem Cells; 2013 Jul; 31(7):1422-33. PubMed ID: 23592522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.
    Kaenel P; Antonijevic M; Richter S; Küchler S; Sutter N; Wotzkow C; Strange R; Andres AC
    Int J Oncol; 2012 Feb; 40(2):357-69. PubMed ID: 22020958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
    Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
    Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.
    LaMarca HL; Visbal AP; Creighton CJ; Liu H; Zhang Y; Behbod F; Rosen JM
    Stem Cells; 2010 Mar; 28(3):535-44. PubMed ID: 20054865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.
    Chiche A; Moumen M; Petit V; Jonkers J; Medina D; Deugnier MA; Faraldo MM; Glukhova MA
    Stem Cells; 2013 Sep; 31(9):1857-67. PubMed ID: 23712598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.
    Vafaizadeh V; Klemmt P; Brendel C; Weber K; Doebele C; Britt K; Grez M; Fehse B; Desriviéres S; Groner B
    Stem Cells; 2010 May; 28(5):928-38. PubMed ID: 20235097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor regulatory networks in mammary epithelial development and tumorigenesis.
    Siegel PM; Muller WJ
    Oncogene; 2010 May; 29(19):2753-9. PubMed ID: 20348953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line.
    Deugnier MA; Faraldo MM; Teulière J; Thiery JP; Medina D; Glukhova MA
    Dev Biol; 2006 May; 293(2):414-25. PubMed ID: 16545360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties.
    Deugnier MA; Faraldo MM; Janji B; Rousselle P; Thiery JP; Glukhova MA
    J Cell Biol; 2002 Nov; 159(3):453-63. PubMed ID: 12427868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland.
    de Visser KE; Ciampricotti M; Michalak EM; Tan DW; Speksnijder EN; Hau CS; Clevers H; Barker N; Jonkers J
    J Pathol; 2012 Nov; 228(3):300-9. PubMed ID: 22926799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating the epithelial hierarchy in the mouse mammary gland.
    Asselin-Labat ML; Vaillant F; Shackleton M; Bouras T; Lindeman GJ; Visvader JE
    Cold Spring Harb Symp Quant Biol; 2008; 73():469-78. PubMed ID: 19022771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luminal progenitors restrict their lineage potential during mammary gland development.
    Rodilla V; Dasti A; Huyghe M; Lafkas D; Laurent C; Reyal F; Fre S
    PLoS Biol; 2015 Feb; 13(2):e1002069. PubMed ID: 25688859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
    Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
    Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Met oncogene and basal-like breast cancer: another culprit to watch out for?
    Gastaldi S; Comoglio PM; Trusolino L
    Breast Cancer Res; 2010; 12(4):208. PubMed ID: 20804567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.
    Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J
    Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.